Evidence for PI3K pathway upregulation was found in virtually all of the NZM lines investigated, although the mechanisms by which this was achieved varied greatly, and it was found that targeting the PI3K pathway in the melanoma cells was most universally effective when done at the level of mTOR. The gene discussed is MTOR; the disease is melanoma.